Royce & Associates LP Boosts Stock Position in Simulations Plus, Inc. $SLP

Royce & Associates LP increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 15.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 402,416 shares of the technology company’s stock after buying an additional 53,658 shares during the period. Royce & Associates LP owned 2.00% of Simulations Plus worth $7,336,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new stake in shares of Simulations Plus in the 2nd quarter worth approximately $25,000. Quarry LP purchased a new stake in Simulations Plus during the 3rd quarter valued at about $28,000. US Bancorp DE grew its position in Simulations Plus by 32.5% during the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after purchasing an additional 1,513 shares during the last quarter. CWM LLC grew its position in Simulations Plus by 160.2% during the 4th quarter. CWM LLC now owns 5,480 shares of the technology company’s stock valued at $100,000 after purchasing an additional 3,374 shares during the last quarter. Finally, State of Wyoming purchased a new stake in Simulations Plus during the 3rd quarter valued at about $136,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Up 7.5%

Shares of SLP opened at $16.71 on Friday. The business’s fifty day simple moving average is $13.74 and its two-hundred day simple moving average is $15.61. Simulations Plus, Inc. has a 12 month low of $11.09 and a 12 month high of $32.51. The company has a market cap of $337.54 million, a price-to-earnings ratio of -5.34 and a beta of 1.28.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The business had revenue of $24.29 million for the quarter, compared to the consensus estimate of $21.66 million. As a group, research analysts forecast that Simulations Plus, Inc. will post 0.85 EPS for the current year.

Analyst Upgrades and Downgrades

SLP has been the topic of several recent analyst reports. Wall Street Zen raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research downgraded shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. Weiss Ratings downgraded shares of Simulations Plus from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st. Finally, TD Cowen cut their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 10th. Three investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $24.40.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.